Regulatory T Cell Therapy for Autoimmune Disease.
- Author:
Tai You HA
1
Author Information
- Publication Type:In Vitro ; Review
- Keywords: autoimmune diseases; rapamycin; regulatory T cells; superantigen; suppressor T cells
- MeSH: Autoimmune Diseases; Autoimmunity; Biology; Graft Rejection; Graft vs Host Disease; Homeostasis; Hypersensitivity; Immunotherapy; Sirolimus; T-Lymphocytes, Regulatory; Tissue Therapy; Transplantation, Homologous; Transplants
- From:Immune Network 2008;8(4):107-123
- CountryRepublic of Korea
- Language:English
- Abstract: It has now been well documented in a variety of models that T regulatory T cells (Treg cells) play a pivotal role in the maintenance of self-tolerance, T cell homeostasis, tumor, allergy, autoimmunity, allograft transplantation and control of microbial infection. Recently, Treg cell are isolated and can be expanded in vitro and in vivo, and their role is the subject of intensive investigation, particularly on the possible Treg cell therapy for various immune-mediated diseases. A growing body of evidence has demonstrated that Treg cells can prevent or even cure a wide range of diseases, including tumor, allergic and autoimmune diseases, transplant rejection, graft-versus-host disease. Currently, a large body of data in the literature has been emerging and provided evidence that clear understanding of Treg cell work will present definite opportunities for successful Treg cell immunotherapy for the treatment of a broad spectrum of diseases. In this Review, I briefly discuss the biology of Treg cells, and summarize efforts to exploit Treg cell therapy for autoimmune diseases. This article also explores recent observations on pharmaceutical agents that abrogate or enhance the function of Treg cells for manipulation of Treg cells for therapeutic purpose.
